Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

17.02
-1.2000-6.59%
Pre-market: 17.020.00000.00%08:46 EDT
Volume:1.60M
Turnover:27.51M
Market Cap:974.80M
PE:-8.74
High:18.46
Open:18.26
Low:16.74
Close:18.22
52wk High:38.11
52wk Low:16.67
Shares:57.27M
Float Shares:54.47M
Volume Ratio:0.91
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9478
EPS(LYR):-1.7207
ROE:-30.24%
ROA:-14.75%
PB:2.87
PE(LYR):-9.89

Loading ...

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Alterity Therapeutics (OtherPRNAF)

TIPRANKS
·
Apr 30

Stock Track | PROCEPT BioRobotics Soars 15.15% After-Hours on Strong Q1 Earnings Beat and Upbeat Guidance

Stock Track
·
Apr 30

Procept BioRobotics Q1 net loss widens 28% to $31.6 million; revenue rises 20% to $83.1 million

Reuters
·
Apr 30

Stock Track | PROCEPT BioRobotics Plummets 7.43% Intraday on Q1 2026 Earnings Results and Outlook

Stock Track
·
Apr 30

PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Procept Biorobotics Q1 Revenue USD 83.132 Million Vs. IBES Estimate USD 80.5 Million

Reuters
·
Apr 30

Procept Biorobotics Q1 EPS USD -0.56

THOMSON REUTERS
·
Apr 30

Procept Biorobotics Outlook FY Revenue Growth 27-33%

THOMSON REUTERS
·
Apr 30

PROCEPT BioRobotics Reports First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 30

Procept BioRobotics files Form 3 for Chief Strat/Marketing Officer Pooja Sharma

Reuters
·
Apr 25

Earning Preview: PROCEPT BioRobotics this quarter’s revenue is expected to increase by 22.57%, and institutional views are predominantly bullish

Earnings Agent
·
Apr 23

Procept BioRobotics announces annual shareholder meeting notice

Reuters
·
Apr 23

PROCEPT BioRobotics (PRCT) Is Up 7.5% After Raising 2026 Revenue Outlook And Sharpening Growth Focus

Simply Wall St.
·
Apr 16

Procept BioRobotics to report first-quarter results, host conference call

Reuters
·
Apr 10

PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026

GlobeNewswire
·
Apr 10